Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/6/2025

Management of Loperamide-Refractory Diarrhea in Colostomy Patients

First-Line Escalation: Opioid Agents

  • The European Society of Clinical Nutrition and Metabolism recommends codeine phosphate 30-60 mg taken 30 minutes before food as the first escalation for loperamide-refractory diarrhea in colostomy patients 1, 2
  • Alternative opioids, such as tincture of opium or morphine, can be used if codeine is ineffective, as suggested by the European Society for Medical Oncology 3
  • Opioid antimotility agents work by increasing duodenal muscle tone, inhibiting propulsive motor activity, and prolonging intestinal transit time, according to the European Society for Clinical Nutrition and Metabolism 4

Second-Line Therapy: Somatostatin Analog

  • The European Society for Medical Oncology recommends octreotide 500 μg subcutaneously three times daily as the next option if opioids fail to control output 7, 4
  • The dose of octreotide can be titrated upward if 500 μg three times daily is insufficient, as suggested by the European Society for Medical Oncology 7, 3
  • Octreotide reduces gastric, biliary, and pancreatic secretions while decreasing intestinal motility, according to the European Society for Clinical Nutrition and Metabolism 4
  • The European Society for Clinical Nutrition and Metabolism recommends monitoring carefully for fluid retention when initiating octreotide 4

Adjunctive Therapies to Consider

  • The European Society of Gastrointestinal Endoscopy suggests that cholestyramine may help bind bile salts that contribute to secretory diarrhea in patients with significant terminal ileum resection 1, 2, 3
  • The European Society for Clinical Nutrition and Metabolism recommends using cholestyramine cautiously, as it can worsen fat malabsorption 1, 2
  • The European Crohn’s and Colitis Organisation suggests that psyllium fiber may slow gastric emptying and improve stool consistency 5, 7
  • The European Society for Medical Oncology recommends using psyllium fiber as an adjunct to antimotility agents 7

Fluid and Electrolyte Management

  • The European Society of Gastrointestinal Endoscopy recommends restricting hypotonic fluids to <1000 mL daily 5
  • The European Crohn’s and Colitis Organisation suggests providing isotonic glucose-saline oral rehydration solution for remaining fluid needs 5
  • The European Society for Clinical Nutrition and Metabolism recommends monitoring serum sodium, potassium, magnesium, and urinary sodium (target urinary sodium >20 mmol/L indicates adequate sodium status) 5
  • The European Society of Gastrointestinal Endoscopy suggests checking for magnesium depletion, which is common and requires replacement 1, 5

Dietary Modifications

  • The European Society of Clinical Nutrition and Metabolism recommends a high carbohydrate (polysaccharides), normal fat, low oxalate diet for patients with retained colon 1, 2
  • The European Society for Medical Oncology suggests avoiding simple sugars and monosaccharides to prevent D-lactic acidosis 1, 2
  • The European Society for Medical Oncology recommends limiting coffee, alcohol, and spices which can worsen diarrhea 3

When to Suspect Complications

  • The European Society of Gastrointestinal Endoscopy recommends looking for red flags such as D-lactic acidosis, characterized by confusion and metabolic acidosis with large anion gap in patients eating high simple carbohydrate diet 1, 2, 8
  • The European Society for Clinical Nutrition and Metabolism suggests considering bacterial overgrowth if dilated bowel segments are present 4
  • The European Crohn’s and Colitis Organisation recommends suspecting inflammatory colitis if fever, bloody output, and abdominal pain are present, which requires corticosteroids, not antimotility agents 6